Peter Lawætz Andersen

Peter Lawætz Andersen


Peter Lawætz Andersen, Faglig direktør, Center f. Vac. Research, ledelse - stab / Center for Vaccine Research
T. 32683462 @.

Peter L. Andersen is Research Director, Center for Vaccine Research at Statens Serum Institut. His research focuses on the identification and characterisation of antigens, immune mechanisms and vaccine delivery systems that mediate protection against important pathogens such as Mycobacterium tuberculosis, Chlamydia trachomatis, Streptococcus pyogenes and Influenza. He has pioneered work on TB and Chlamydia vaccines, the CAF series of liposomal adjuvants and novel TB diagnostic assays and reagents.

In his current position, he is responsible for the overall coordination of vaccine research and development covering activities from early research to clinical development. This program currently has two TB vaccines in late stage clinical testing and different liposomal adjuvant formulations and a novel Chlamydia trachomatis vaccine in phase 1 trials. The program also has a number of advanced novel and innovative vaccine modalities in late stage preclinical evaluation. In collaboration with industrial partners, his team has developed novel TB diagnostic tests (the IGRA assays) that are in widespread worldwide clinical use today and has recently completed a large-scale phase 3 testing of a novel specific skin test reagent to substitute for tuberculin.

Peter Andersen has an extensive scientific production of 380 papers (H-index 94 WoS/ 104 Google Scolar), over 20 patents and has given lectures all over the world. He was recognized by Thomson Scientific as the most cited researcher in Denmark within the field of immunology (1990 to 2005), and as one of the most cited researchers in the world within the diverse field of Tuberculosis (2009). Peter Andersen heads several international research consortiums, has organized and chaired many international meetings, and received numerous large national and international research grants. He has received several prizes and awards and in 2011 he received the Novo Nordisk Prize; the most prestigious Danish award given as an acknowledgement for a lifetime scientific achievement. Peter Andersen is a member of the Danish Research Council and Professor of Infectious Disease Immunology at the Department of Immunology and Microbiology, University of Copenhagen, Denmark.